PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
TD The Market Publishers, Ltd
Sponsored Company

Company Overview

Products & Services

Contact Info & Offices

Press Releases

TD The Market Publishers, Ltd

Press Release


Receive press releases from TD The Market Publishers, Ltd: By Email RSS Feeds:

New Immunotherapy Report Package by La Merie Publishing Now Available at MarketPublishers.com


London, United Kingdom, December 01, 2017 --(PR.com)-- As a quite versatile therapeutic modality, mRNA provides a number of advantages to its users. It can help with reaching transient expression of the encoded protein, as it lacks genomic integration. mRNA boasts a favorable safety profile that makes it attractive for gene editing and vaccines.

Being well defined chemically, it can be reproducibly manufactured at high yield, activity and purity. Oncolytic viruses have the power of directly lysing cancer cells, and they also free tumor-specific neoantigents, as they can indirectly act as a cancer vaccine.

Oncolytic viruses have modest efficacy, which can be improved when it is combined with immune checkpoint inhibitors. As a result, leading immuno-oncology (I-O) players and investors become increasingly interested in partnering with oncolytic viruses’ specialists.

New report package “Immunotherapy with Oncolytic Viruses and mRNA Vaccines & Therapeutics” (available at http://bit.ly/2BmZFyG) drawn up by La Merie Publishing offers an up-close look at the global immunotherapy landscape, with a focus on oncolytic viruses and mRNA vaccines and therapeutics.

The research study starts with an all-round discussion of the today’s therapeutic landscape. It profiles existing vaccines based on mRNA and therapeutics. The report comprehensively examines the pipeline and casts light on selected mRNA and delivery technologies.

It covers technologies by reviewing mRNA modifications and efficiencies, covering carriers for mRNA-based therapeutics, and more. The study also comprises profiles of major players worldwide: PhaseRx, Tiba Biotechnology, Acuitas Thereaputics, MaxCyte, Bayer, Merck, and Sanofi, to name a few.

The research report also examines major stakeholders and limelights mRNA’s financial perspective. Future outlook for the marketplace is also presented in the package.

More market research reports are available at https://marketpublishers.com.

About the company:

TD The Market Publishers, Ltd. gives access to an extensive collection of topical research reports investigating different markets. It supplies its customers with periodical publications, databooks, on-line subscriber services and much more. The company's report database is updated daily. Market Publishers is always ready to supply updated information on the target markets to its customers. Market Publishers' online research reports hypermarket includes over 1.5 million publications, so it is able to satisfy demand of the most exacting clients.
Contact Information
TD The Market Publishers, Ltd.
Natalie Aster
+44 208 144 6009
Contact
https://marketpublishers.com

Click here to view the company profile of TD The Market Publishers, Ltd
Click here to view the list of recent Press Releases from TD The Market Publishers, Ltd
Promote Your Business